Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC6398166/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC6398166/. The analysis below is for the second page.

Title[redir]:
Targeting minimal residual disease: a path to cure? - PMC
Description:
Therapeutics that block kinases, transcriptional modifiers, immune checkpoints and other biological vulnerabilities are transforming cancer treatment. As a result, many patients achieve dramatic responses, including complete radiographic or ...

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We don’t know how the website earns money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Ncbi.nlm.nih.gov might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

scholar, google, pubmed, doi, mrd, cells, cancer, pmc, article, free, patients, therapy, cell, tumour, residual, acute, response, leukemia, minimal, disease, oncol, treatment, relapse, therapeutic, nat, single, blood, drug, clin, chemotherapy, functional, multiple, assay, assays, clinical, testing, approaches, singlecell, cytometry, lymphoblastic, selection, mass, targeting, cml, patient, flow, therapeutics, myeloid, resistance, mar,

Topics {✒️}

single-cell rna-seq supports transcriptomics single-cell rna-seq net pro-apoptotic signalling cell-free nucleic acids circulating-free tumor dna bcr–abl fusion kinase48 intraductal papillary-mucinous tumors df/koch bridge program oncogene withdrawal-induced apoptosis dynamic bh3 profiling single-cell mass accumulation single-cell rna-seq empowering single-cell ‘omics pmc beta search live-cell downstream assays alk-rearranged lung adenocarcinoma precede longer-term phenotypes dana-farber cancer institute small-cell lung cancer low-cost rna sequencing single-cell rna sequencing guide therapy decision-making cell free dna muscle-invasive bladder cancer long-term therapeutic pressure egfr-mutated lung cancer opinion article argues single-cell transcriptomics applied fixable bh3 profiling assay quantifies treatment-induced drug-free holidays measure single-cell response bcr–abl transcript mass accumulation rate patient-derived tumour xenografts nucleic acid-based biomarkers single-cell growth rates t-cell receptor relapse free survival pre-enrichment based flow cytometry-based dbp marker-free isolation real-time deformability cytometry minimal residual disease egfr-mutant nsclc patients tyrosine kinase inhibitors cancer precision medicine sc-rna-seq early immunophenotypic evaluation nucleic acids derived

Questions {❓}

  • Bruggemann M, Raff T & Kneba M Has MRD monitoring superseded other prognostic factors in adult ALL?
  • Martin OA, Anderson RL, Narayan K & MacManus MP Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?
  • Ossenkoppele G & Schuurhuis GJ MRD in AML: does it already guide therapy decision-making?
  • Targeting minimal residual disease: a path to cure?

Social Networks {👍}(6)

External Links {🔗}(270)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.88s.